Company Search:
Advanced Search
Sponsored Links
CEL-SCI Corporation Company Snapshot
CEL-SCI Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CEL-SCI with three other companies in this sector in UNITED STATES : Cardiff Oncology Inc (2019 sales of $244,632.00 of which 100% was Biological Product), Windtree Therapeutics Inc ($198,000.00 of which 100% was Biopharmaceutical and Medical device), and Enzon Pharmaceuticals, Inc. ($207,000.00 ).

Sales Analysis. CEL-SCI reported sales of $462,754.00 for the fiscal year ending September of 2019. This represents a decrease of 2.9% versus 2018, when the company's sales were $476,556.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CEL-SCI Corporation
  Stock Performance Chart for CEL-SCI Corporation
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 12.51
(Figures in U.S. Dollars)
1 Week -5.9%   13 Weeks -7.5%  
4 Weeks -23.5%   52 Weeks 67.2%  
CEL-SCI Corporation Key Data:
  Ticker: CVM Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 462,754
(Year Ending Jan 2020).
Employees: 41
  Currency: U.S. Dollars Market Cap: 467,078,502
  Fiscal Yr Ends: September Shares Outstanding: 37,336,411
  Share Type: Common Closely Held Shares: 1,670,840
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.